Common Contracts

EX-10.15 24 d788220dex1015.htm EX-10.15 ***Text Omitted and Filed Separately with the Securities and Exchange Commission Confidential Treatment Requested Under 17 C.F.R. Sections 200.80(b)(4) and 230.406 AMENDED AND RESTATED LICENSE AGREEMENT

License Agreement • May 5th, 2020 • New York

• Contract Type
  License Agreement
• Filed
  May 5th, 2020
• Jurisdiction
  New York

This Amended and Restated License Agreement (this “Agreement”) is made effective as of March 7, 2011 (the “Effective Date”) by and between ARIAD Pharmaceuticals, Inc., a Delaware corporation with its principal place of business at 26 Landsdowne Street, Cambridge, MA 02139 (“ARIAD”), and Bellicum Pharmaceuticals, Inc., a Delaware corporation with a place of business at 6400 Fannin St., Suite 2300, Houston, TX 77030 (“Bellicum”). ARIAD and Bellicum are each hereafter referred to individually as a “Party” and together as the “Parties”.

AMENDED AND RESTATED LICENSE AGREEMENT

License Agreement • November 18th, 2014 • Bellicum Pharmaceuticals, Inc • Pharmaceutical preparations • New York

• Contract Type
  License Agreement
• Filed
  November 18th, 2014
• Company
  Bellicum Pharmaceuticals, Inc
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

This Amended and Restated License Agreement (this “Agreement”) is made effective as of March 7, 2011 (the “Effective Date”) by and between ARIAD Pharmaceuticals, Inc., a Delaware corporation with its principal place of business at 26 Landsdowne Street, Cambridge, MA 02139 (“ARIAD”), and Bellicum Pharmaceuticals, Inc., a Delaware corporation with a place of business at 6400 Fannin St., Suite 2300, Houston, TX 77030 (“Bellicum”). ARIAD and Bellicum are each hereafter referred to individually as a “Party” and together as the “Parties”.

AMENDED AND RESTATED LICENSE AGREEMENT

License Agreement • October 17th, 2014 • Bellicum Pharmaceuticals, Inc • Pharmaceutical preparations • New York

• Contract Type
  License Agreement
• Filed
  October 17th, 2014
• Company
  Bellicum Pharmaceuticals, Inc
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

This Amended and Restated License Agreement (this “Agreement”) is made effective as of March 7, 2011 (the “Effective Date”) by and between ARIAD Pharmaceuticals, Inc., a Delaware corporation with its principal place of business at 26 Landsdowne Street, Cambridge, MA 02139 (“ARIAD”), and Bellicum Pharmaceuticals, Inc., a Delaware corporation with a place of business at 6400 Fannin St., Suite 2300, Houston, TX 77030 (“Bellicum”). ARIAD and Bellicum are each hereafter referred to individually as a “Party” and together as the “Parties”.